Arcutis Biotherapeutics Inc. (ARQT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Arcutis Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Arcutis Biotherapeutics Inc. (ARQT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $4.0B. It trades at $31.45, down 0.73% today, at 136.3 times earnings. Its overall quality score is 70 out of 100, ranked against the whole US market. 6 analysts' average target of $39.83 implies +26.6% from today's price. Kronos AI's 30-day forecast is −21.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $39.83 |
| Low – high | $34.00 – $48.00 |
| Analysts | 6 |
| Upside to average | +26.6% |
Kronos AI 30-day forecast
| Expected close | $24.96 (−21.2%) |
| Likely range | −22.4% … −20.0% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 63 |
| Solvency | 58 |
| Growth | 89 |
| Overall | 70 |
| P/E | 136.3 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator